Konstanze D. Scheffer

427 total citations
8 papers, 344 citations indexed

About

Konstanze D. Scheffer is a scholar working on Immunology, Epidemiology and Cell Biology. According to data from OpenAlex, Konstanze D. Scheffer has authored 8 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Epidemiology and 3 papers in Cell Biology. Recurrent topics in Konstanze D. Scheffer's work include Cervical Cancer and HPV Research (3 papers), Cell Adhesion Molecules Research (3 papers) and Proteoglycans and glycosaminoglycans research (3 papers). Konstanze D. Scheffer is often cited by papers focused on Cervical Cancer and HPV Research (3 papers), Cell Adhesion Molecules Research (3 papers) and Proteoglycans and glycosaminoglycans research (3 papers). Konstanze D. Scheffer collaborates with scholars based in Germany, United Kingdom and United States. Konstanze D. Scheffer's co-authors include Luise Florin, Fedor Berditchevski, Gilles A. Spoden, Carsten Lambert, Xin A. Zhang, Fatima Boukhallouk, Thorsten Lang, Jan-Gero Schloetel, Ružica Bago and Sundaresan Rajesh and has published in prestigious journals such as Journal of Virology, Scientific Reports and Biophysical Journal.

In The Last Decade

Konstanze D. Scheffer

8 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Konstanze D. Scheffer Germany 8 133 132 126 87 52 8 344
Xavier Dervillez France 14 199 1.5× 181 1.4× 130 1.0× 52 0.6× 42 0.8× 20 469
Adem C. Koksal United States 9 130 1.0× 59 0.4× 247 2.0× 92 1.1× 56 1.1× 13 494
M T Michalek United States 10 304 2.3× 59 0.4× 247 2.0× 39 0.4× 64 1.2× 13 490
Elizabeth Payne Australia 9 164 1.2× 173 1.3× 142 1.1× 23 0.3× 88 1.7× 12 409
Patrick Nédellec Canada 10 92 0.7× 65 0.5× 220 1.7× 43 0.5× 81 1.6× 14 481
Claire Lastrucci France 12 272 2.0× 104 0.8× 192 1.5× 41 0.5× 62 1.2× 12 523
François Jordier France 11 130 1.0× 93 0.7× 139 1.1× 12 0.1× 48 0.9× 15 374
David Bockstoce United States 7 223 1.7× 68 0.5× 153 1.2× 43 0.5× 98 1.9× 8 500
Alexandra Veit Germany 11 127 1.0× 43 0.3× 138 1.1× 50 0.6× 20 0.4× 13 411
Laurent Vidard France 10 402 3.0× 51 0.4× 119 0.9× 54 0.6× 112 2.2× 18 536

Countries citing papers authored by Konstanze D. Scheffer

Since Specialization
Citations

This map shows the geographic impact of Konstanze D. Scheffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konstanze D. Scheffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konstanze D. Scheffer more than expected).

Fields of papers citing papers by Konstanze D. Scheffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konstanze D. Scheffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konstanze D. Scheffer. The network helps show where Konstanze D. Scheffer may publish in the future.

Co-authorship network of co-authors of Konstanze D. Scheffer

This figure shows the co-authorship network connecting the top 25 collaborators of Konstanze D. Scheffer. A scholar is included among the top collaborators of Konstanze D. Scheffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konstanze D. Scheffer. Konstanze D. Scheffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Scheffer, Konstanze D., et al.. (2020). Tetraspanin CD9 affects HPV16 infection by modulating ADAM17 activity and the ERK signalling pathway. Medical Microbiology and Immunology. 209(4). 461–471. 16 indexed citations
2.
Scheffer, Konstanze D., Fatima Boukhallouk, Gilles A. Spoden, et al.. (2016). The CD63-Syntenin-1 Complex Controls Post-Endocytic Trafficking of Oncogenic Human Papillomaviruses. Scientific Reports. 6(1). 32337–32337. 72 indexed citations
3.
Homsi, Yahya, Jan-Gero Schloetel, Konstanze D. Scheffer, et al.. (2014). The Extracellular δ-Domain is Essential for the Formation of CD81 Tetraspanin Webs. Biophysical Journal. 107(1). 100–113. 40 indexed citations
4.
Spoden, Gilles A., Konstanze D. Scheffer, Jef K. De Brabander, et al.. (2014). Inhibition by Cellular Vacuolar ATPase Impairs Human Papillomavirus Uncoating and Infection. Antimicrobial Agents and Chemotherapy. 58(5). 2905–2911. 27 indexed citations
5.
Scheffer, Konstanze D., Fedor Berditchevski, & Luise Florin. (2014). The Tetraspanin CD151 in Papillomavirus Infection. Viruses. 6(2). 893–908. 39 indexed citations
6.
Scheffer, Konstanze D., Ruth Popa-Wagner, & Luise Florin. (2013). Isolation and Characterization of Pathogen-Bearing Endosomes Enable Analysis of Endosomal Escape and Identification of New Cellular Cofactors of Infection. Methods in molecular biology. 1064. 101–113. 10 indexed citations
7.
Scheffer, Konstanze D., Gilles A. Spoden, Xin A. Zhang, et al.. (2013). Tetraspanin CD151 Mediates Papillomavirus Type 16 Endocytosis. Journal of Virology. 87(6). 3435–3446. 118 indexed citations
8.
Scheffer, Konstanze D., Timo Bund, Fatima Boukhallouk, et al.. (2013). The Transcription Factors TBX2 and TBX3 Interact with Human Papillomavirus 16 (HPV16) L2 and Repress the Long Control Region of HPVs. Journal of Virology. 87(8). 4461–4474. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026